All peptides
Tirzepatide
Also known as: Mounjaro / Zepbound
FDA-Approved
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management.
Buy Tirzepatide on American Peptides
Affiliate link — we may earn a commission at no extra cost to you.
Overview
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management.
FDA Approval Status
Approved by the FDA for at least one medical indication (see approved uses below).
Mechanism of Action
Co-agonism of GIP and GLP-1 receptors enhances insulin secretion, suppresses appetite, and improves lipid handling.
Current Research
SURPASS and SURMOUNT trial programs demonstrated superior weight and glycemic outcomes.
Research strength: Strong
Potential Medical Uses
- Type 2 diabetes
- Chronic weight management
Potential Benefits
- Substantial A1C and weight reductions
- Improved cardiometabolic markers
Known Side Effects
- Nausea
- Diarrhea
- Constipation
- Injection-site reactions
Contraindications
- MTC/MEN 2 history
- Hypersensitivity
Drug Interactions
- Insulin/sulfonylureas
- Oral contraceptives (advise backup for oral pills)
Administration Methods
- Subcutaneous injection weekly
Half-life
~5 days
Reconstitution
Prefilled pen; no reconstitution.
Storage & Handling
Refrigerate; may be kept at room temperature briefly per label.
References & Sources
Frequently Asked Questions
Information on this page is educational and general in nature. It is not medical advice. Consult a qualified healthcare professional before making any medical decisions.